You are here

Big pharma turns to wearables to track participants in clinical trials

Washington

PHARMACEUTICAL companies are enlisting Fitbits and other gadgets strapped to patients' wrists, chests and skin as a way to bring drugs to market faster.

What began as an aid for athletes and dieters to track their movements is quickly becoming a critical tool for medical